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The  difference  in  sex-chromosome  make-up  between 
mammalian males (XY) and females (XX) has led to the 
evolution  of  two  main  dosage-compensation  mecha-
nisms: upregulation of the active X chromosome (Xa) in 
both sexes to balance X expression with the autosomes; 
and  inactivation  of  one  X  chromosome  in  females  to 
avoid X hyperexpression and correct for the difference in 
gene dosage between the sexes [1-3] (see Box 1). These 
mechanisms evolved to compensate for the presence of 
only one copy (haploinsufficiency) of X-linked genes in 
males due to degeneration of the Y chromosome from its 
origin as an X homolog [4]. Suppression of recombination 
between the sex chromosomes was apparently mediated 
by large Y inversions, as deduced by remnant X/Y homo-
logy. This led to Y degeneration due to accumulation of 
mutations  and  inability  to  restore  the  correct  DNA 
sequence  [5,6].  Only  small  regions  of  homology  and 
pairing  between  the  sex  chromosomes  remain,  called 
pseudoautosomal  regions  (PARs)  because  genes  within 
these regions behave like autosomal genes.
Initiation of X inactivation in female embryos depends 
on the transcription of the long noncoding RNA XIST/
Xist  (X-inactive  specific  transcript)  from  one  chromo-
some (which will become the inactive X (Xi)) and recruit-
ment of a protein complex important for X-chromosome 
silencing  and  heterochromatin  formation  [7,8].  In 
humans, XIST (17 kb in size) is located in the long arm of 
the X chromosome, whereas in mice where there is only 
one  arm,  Xist  (15  kb  in  size)  is  in  the  middle  of  the 
chromosome. Xist RNA spreads along the X chromosome 
in  cis  and  recruits  a  protein  complex  responsible  for 
deposition of repressive histone modifications onto the Xi 
[9-11]. As a result the Xi becomes heterochromatic, silent 
and  condensed.  Before  implantation,  X  inactivation  is 
imprinted, with the paternal X chromosome always being 
silenced. At the blastocyst stage, the paternal X reactivates 
and random X inactivation takes place (see Box 1).
Although  most  genes  on  the  Xi  are  silenced,  some 
genes remain expressed from both the Xa and the Xi. Not 
surprisingly,  genes  that  retain  a  Y-linked  copy  -  for 
example,  Kdm5c  and  Kdm5d  (which  encode  histone 
demethylases) - escape X inactivation and thus have two 
expressed alleles in both male and female somatic tissues. 
However,  not  all  ‘escaping’  genes  have  a  Y  copy,  for 
example  Car5b  (carbonic  anhydrase).  Recent  reports 
have  shown  striking  differences  between  human  and 
mouse  regarding  the  identity  and  number  of  these 
‘escape’ genes in somatic tissues [12,13]. Why are there 
such species differences? Structural differences between 
the X chromosomes may play a role as well as selective 
pressure to maintain sex differences.
Escape  from  X  inactivation  is  not  limited  to  female 
somatic cells. Indeed, another type of silencing of the X 
takes place in male germ cells and is known as meiotic 
sex chromosome inactivation (MSCI; see Box 1). MSCI 
results in silencing of protein-coding messenger RNAs 
from the X chromosome, but a majority of the X-linked 
microRNAs  (miRNAs)  escape  MSCI,  suggesting  that 
they  play  a  role  in  male  meiosis  [14].  How  do  genes 
escape silencing on the heterochromatic X chromosome, 
whether  in  somatic  or  germ  cells?  Many  studies  have 
shown  that  epigenetics  plays  a  crucial  role  in  X 
inactivation  and  escape  [7,15].  In  this  review,  we  will 
summarize recent progress made in the field of escape 
from  X  inactivation,  compare  the  number  and  distri-
bution of human and mouse escape genes, and discuss 
possible  molecular  mechanisms  involved  in  genes 
escaping X inactivation.
Differences in escape genes between humans and 
mice
We shall first deal with the main type of X inactivation - 
that  is,  random  X-chromosome  inactivation  in  female 
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linked genes consistently escape this type of X inactiva-
tion,  as  determined  from  their  expression  in  rodent  x 
human  hybrid  cells  that  retain  the  human  Xi,  and  on 
measurements  of  relative  expression  of  allelic  poly-
morphisms  in  primary  fibroblasts  [12].  Many  human 
genes  escaping  X  inactivation  have  already  lost  their 
corres  ponding Y copy. This suggests either that establish-
ment of X inactivation may lag behind Y degeneration, or 
that  specific  mechanisms  may  exist  to  maintain 
expression of a subset of genes from the Xi as the result 
of selective advantages. In the mouse, we have recently 
shown that only 3% of genes escape X inactivation using 
next-generation RNA sequencing to survey allele-specific 
expression of X-linked genes. We derived a cell line from 
a mouse resulting from a cross between two species of 
mice, Mus spretus and Mus musculus, which are separ-
ated by as much as 7 million years of evolution and thus 
differ by numerous DNA sequence variants (about one 
variant for every 100 base pairs). These variant sequences 
were exploited to determine expression from each allele 
of  X-linked  genes  after  RNA  sequencing.  Because  X 
inactivation is random, we selected for cells with the M. 
musculus  X  chromosome  inactive  to  achieve  100% 
skewing of X inactivation [13]. Following this approach, 
any gene with RNA sequence reads from both species of 
mice was classified as an escape gene. From this study we 
conclude that compared to humans, X inactivation in the 
mouse is more complete (Figure 1).
Escape  from  X  inactivation  in  other  mammalian 
species has not been extensively characterized. None  the-
less,  escape  genes  have  been  identified  in  marsupials, 
which  differ  from  eutherian  mammals  in  terms  of  key 
features of X inactivation - Xist is absent and the paternal 
X always silenced. At least four X-linked genes encoding 
glucose-6-phosphate dehydrogenase (G6PD), hypoxanthine 
guanine  phosphoribosyl  transferase  (HPRT),  phospho-
glycerate  kinase  (PGK1),  and  a  monocarboxylic  acid 
transporter  (SLC16A2)  show  incomplete  silencing  in  a 
tissue-  and  species-dependent  manner  in  marsupial 
females [16,17].
Significant differences exist in terms of the distribution 
of escape genes in human and mouse. In humans, most 
escape genes are located on the X short arm. One reason 
for this could be because the short arm has most recently 
diverged  from  the  Y,  and  so  these  genes  have  only 
recently  (in  evolutionary  terms)  lost  their  Y  paralogs 
[5,6,12]. Alternatively, the centromeric heterochromatin 
might exert a barrier effect that would prevent sufficient 
spreading of XIST RNA, which is generated from the X-
inactivation  center  located  in  the  long  arm  [18].  In 
contrast, escape genes are randomly distributed along the 
mouse X chromosome, which has its centromere located 
at one end [13]. In humans, escape genes are clustered (as 
many as 13 adjacent genes in large domains ranging in 
size between approximately 100 kb and 7 Mb), whereas in 
mouse, single genes are embedded in regions of silenced 
chromatin (Figure 2a). This suggests that escape from X 
inactivation  in  mouse  is  controlled  at  the  level  of 
individual  genes  rather  than  chromatin  domains 
[12,13,19].
In  both  human  and  mouse,  many  of  the  genes  that 
escape  X  inactivation  are  expressed  more  strongly  in 
females. In fact, one study has identified escape genes on 
the  basis  of  expression  levels  in  women  with  different 
numbers  of  X  chromosomes  [20].  However,  in  both 
humans and mice, differences in levels of expression of 
the escape genes between males and females are small, 
indicating partial repression of the escape genes on the 
Box 1. Regulation of the X chromosome in eutherian 
mammals
X upregulation is the process by which the active 
X chromosome (Xa) is upregulated in both sexes to balance 
expression between the X and the autosomes. The molecular 
mechanisms of the process are unknown.
Random X inactivation is the process by which one 
X chromosome is silenced in female embryos in order to avoid 
X hyperexpression due to X upregulation and to balance gene 
dosage between the sexes. Random X inactivation silences either 
the paternal or maternal X chromosome at the blastocyst stage 
and persists into adulthood. The noncoding RNA transcribed 
from Xist is essential for the onset of silencing. Xist RNA coats the 
X chromosome in cis and recruits a protein complex to establish 
repressive epigenetic modifications and implement gene 
silencing. Escape from random X inactivation affects about 15% 
of human genes and 3% of mouse genes, most of these genes 
being protein coding.
Imprinted paternal X inactivation is the process by which 
the paternal X chromosome is silenced in early female embryos 
before implantation. This paternal X inactivation persists in 
extraembryonic tissues (as shown in mice, but not well studied 
in humans) but is reversed in the inner cell mass before random 
X inactivation. This silencing process is Xist dependent, although 
it is controversial whether Xist is necessary for initiation. Escape 
from imprinted paternal X inactivation has been observed for 
some genes (which may differ from those that escape random 
X inactivation), but no complete survey is available.
Meiotic sex-chromosome inactivation (MSCI) is the process 
of silencing of both the X and Y chromosomes in male meiosis 
and occurs in almost all organisms that have differentiated sex 
chromosomes, including humans. As in somatic X inactivation, 
Xist RNA coats the X chromosome during MSCI. However, Xist is 
not required for silencing. MSCI is associated with recruitment 
of DNA repair proteins such as the histone variant H2AX and 
MDC1 (mediator of DNA damage checkpoint 1). Escape from 
MSCI characterizes a set of miRNA genes such as mir-221, 
mir-374, mir-470 and mir-741, which may be important for 
spermatogenesis.
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Page 2 of 7Xi  [21,22].  This  was  confirmed  by  measuring  allele-
specific  expression  of  escape  genes  in  humans  and  in 
mice [12,13]. We hypothesize that the Xi allele is either 
partially silenced by adjacent repressive modifications or 
might lack modifications associated with X upregulation 
of  the  Xa.  As  we  do  not  know  yet  what  these 
modifications are, this hypothesis remains to be tested. It 
is expected that, compared with mice, men and women 
would  demonstrate  greater  sex  differences  in  X-linked 
gene expression as a result of the large number of escape 
genes. Whether such sex differences provide an evolu-
tionary advantage remains to be explored. Possible evo-
lutionary  advantages  would  be,  for  example,  higher 
expression  in  female  reproductive  organs  or  in  neuro-
logical tissues, which could influence behavior. It should 
be  noted  that  most  studies  about  escape  from  X 
inactivation have been done using cell lines; thus, tissue-
specific effects have not been fully addressed.
Role of escape genes in disease
Escape genes play important roles in human diseases as 
women  with  a  single  X  chromosome  (X-chromosome 
monosomy;  45,X)  have  Turner  syndrome,  with  severe 
phenotypes including ovarian dysgenesis, short stature, 
webbed neck, and other physical abnormalities [23]. In 
addition, as many as 99% of 45,X embryos die in utero 
[24]. Deficiency in escape genes is thought to play a major 
role  in  phenotypes  observed  in  Turner  patients  [25]. 
Because  the  Y  chromosome  protects  men  from  these 
deficiencies, the most likely candidate genes would have a 
Y  copy,  except  for  genes  that  control  female-specific 
pheno  types such as ovarian failure and thus, by defini-
tion, would not affect men. So far, the pseudoautosomal 
gene  SHOX  (SHORT  STATURE  HOMEBOX),  which 
encodes a homeodomain transcription factor, is the only 
gene directly implicated in the short-stature phenotype 
[26]. Interestingly, early lethality of 45,X embryos may be 
due  to  a  defect  in  placenta  differentiation,  which  is 
supported by the finding that many placental genes have 
much  higher  expression  in  46,XX  versus  45,X  cells  in 
differentiated  human  embryonic  stem  (ES)  cells  [27]. 
Notably,  the  pseudoautosomal  gene  CSF2RA  (colony-
stimulating  factor  2  receptor,  alpha),  which  encodes  a 
receptor  for  a  hematopoietic  differentiation  factor,  has 
more  than  ninefold  higher  expression  in  46,XX  versus 
45,X cells, suggesting that this gene may be involved in 
placenta differentiation defects [27]. In contrast, X0 mice 
have a near-normal phenotype and are fertile, although 
the number of oocytes is reduced, potentially as a result 
of  the  lack  of  sex-chromosome  pairing  [28].  Meiotic 
arrest due to lack of pairing could be attenuated in mouse 
compared with human single-X oocytes because of self-
pairing of the X in mouse [29].
The fact that few escape genes exist in the mouse is 
consistent with the significant differences in the impact 
of  X-chromosome  monosomy  in  female  mice  and  in 
women [13]. Genes that escape from X inactivation in 
humans but are subject to X inactivation in the mouse 
may be good candidates for genes responsible for Turner 
syndrome  severe  phenotypes.  Pseudoautosomal  genes 
Figure 1. More genes escape X inactivation in humans than in 
the mouse. Distribution of genes subject to X inactivation (blue) and 
of ‘escape’ genes (orange) in human and mouse. The position of the 
pseudoautosomal regions (PAR1 and 2 in human, PAR in mouse), of 
the centromeres (cen, purple bar), and of the X-inactivation center 
encoding the long noncoding RNA XIST/Xist (black bar) are indicated. 
Note that as the centromere is located at one end of the mouse 
X chromosome, there is no short arm or long arm. Data from Carrel 
and Willard [12] and Yang et al. [13].
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demonstrated  for  SHOX,  and  possibly  for  CSF2RA. 
Indeed,  the  mouse  pseudoautosomal  region  contains 
only  one  gene,  Sts  (steroid  sulfatase)  [30],  whereas  all 
genes located in the pseudoautosomal region in humans 
are autosomal in the mouse and thus are not affected in 
X0 mice [31].
Another potential role for escape from X inactivation is 
in aging. Inappropriate reactivation of an X-linked gene, 
Otc, which encodes a urea cycle enzyme called ornithine 
transcarbamoylase, has been reported in mouse tissues 
[32]. Furthermore, a recent study has found epigenetic 
alterations including X reactivation in a mouse model of 
accelerated aging due to telomere shortening [33]. So far, 
no such reactivation of X-linked genes has been observed 
in  humans.  It  will  be  important  to  determine  whether 
environmental factors could cause inappropriate escape 
from X inactivation due to changes in epigenetic marks.
Chromatin modifications and escape from X 
inactivation
The Xi is distinguishable from its active counterpart by 
its epigenetic marks, including coating with Xist RNA. 
This is the earliest event in X inactivation during embryo-
genesis, and gene silencing follows within one or two cell 
cycles [7]. Interestingly, Xist-induced silencing can only 
be achieved in early differentiating ES cells, and reaches a 
point of irreversibility. Just how Xist RNA is spread along 
the  Xi  is  still  not  fully  understood.  One  hypothesis 
suggests that long interspersed repetitive elements (L1) 
repeats are overrepresented on the X and may serve as 
‘booster’  elements  by  anchoring  Xist  RNA  to  the 
chromosome, thus aiding spreading [34]. Consistent with 
this hypothesis, human genes that escape X inactivation 
have  fewer  L1  repeats  [6,35,36].  These  genes  are  also 
enriched in specific sequence motifs such as Alu repeats 
and short motifs containing ACG/CGT at their 5’ ends 
[37]. In the mouse, another type of repeat - long terminal 
repeats (LTRs) - appears to be depleted on escape genes 
[19].  These  observations  imply  that  Xist  RNA  coating 
could be deficient at genes escaping X inactivation. This 
was  recently  demonstrated  in  mouse  myoblasts  using 
RNA tagging and recovery of associated DNA (modified 
TRAP) method for identification of targets [38]. In this 
study,  escapees  Kdm5c  and  Kdm6a,  which  encode 
chromatin-modifying histone lysine demethylases, were 
Figure 2. Silenced and escape regions have distinct chromatin marks. (a) Chromatin containing escape genes is excluded from the condensed 
heterochromatic body of the Xi. In mouse, individual escape genes are surrounded by inactivated chromatin. In contrast, human escape genes 
exist in domains comprising clusters of genes. Orange bars represent escape genes and blue bars inactivated genes. (b) Silenced chromatin in the 
Xi is coated by Xist RNA potentially via specific DNA motifs (green). Repressive histone modifications and histone variants (for example, H3K27me3, 
H3K9me3, H4K20me3, and macroH2A1) are recruited and DNA methylation modifies the CpG islands. This type of chromatin structure prevents 
transcription (blue bar below). In contrast, escape gene regions are enriched for permissive histone marks (for example, H3K4me3, and H3 and H4 
acetylation) and RNA polymerase II (RNA pol II) and are hypomethylated at their CpG islands. Insulator sites bound by the insulator protein CTCF, 
together with unknown factors (as denoted by the ‘?’), may separate inactivated genes (blue bar) from active genes (orange bar). CTCF binding may 
block CpG methylation and the spread of repressive chromatin and/or may organize the chromatin into loops.
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Page 4 of 7shown  to  be  devoid  of  Xist  RNA  coating  over  their 
promoters  and  transcribed  regions.  Conversely,  genes 
subjected  to  X  inactivation,  and  L1  repeat  elements 
themselves, recruited Xist RNA [38] (Figure 2b). Taken 
together, these studies support the idea that specific DNA 
sequence motifs are involved in recruitment of Xist RNA 
to the Xi.
While Xist RNA coating is important in the initiation 
of  X  inactivation,  many  other  epigenetic  modifications 
follow to silence the X and maintain silencing. An early 
repressive chromatin mark, tri-methylation of lysine 27 
on histone H3 (H3K27me3), is recruited by the Polycomb 
complex  of  chromatin-modifying  proteins,  resulting  in 
compaction of the silenced portion of the Xi (Figure 2a). 
Other  repressive  marks  include  H3K9me3  and  the 
histone variant macroH2A1, which are also enriched on 
the Xi (Figure 2b) [7,39]. Concomitantly, ‘active’ marks 
such as acetylation of histone H3 and H4 are lost from 
the silenced chromatin [7,40]. Modifications charac  ter-
istic of silenced genes contrast with those within escape 
genes, which remain euchromatic and harbor histone H3 
and  H4  acetylation  [7,41].  H3K4me3,  another  mark 
associated  with  transcriptional  activity,  is  absent  from 
most of the Xi except at discrete regions corresponding 
to areas of escape, as shown in female lymphoblasts [42] 
(Figure  2b).  We  recently  demonstrated  a  lack  of 
H3K27me3  at  escape  genes  in  mouse,  which  shows 
complete concordance in the cell line used to assay allelic 
expression [13].
The  existence  of  discrete  areas  of  ‘escape  chromatin’ 
adjacent  to  silenced  chromatin  suggests  the  need  for 
boundary  elements,  such  as  insulator  sequences,  that 
may block the spreading of heterochromatin into escape 
regions or prevent repressive marks from being added to 
escape domains (Figure 2). Supporting this idea are our 
findings  that  the  insulator  protein  CTCF  (CCCTC-
binding factor), which binds known insulator sequences, 
binds to the transition region between the escape gene 
Kdm5c  and  the  inactivated  gene  Iqsec2  (IQ  motif  and 
SEC7 domain-containing protein 2) in mouse, whereas in 
humans,  the  corresponding  region  between  the  same 
genes, which both escape X inactivation, does not bind 
CTCF [43]. Furthermore, we have found that the CpG 
island at the 5’ end of Kdm5c remains hypomethylated 
throughout  mouse  development,  possibly  because  it  is 
rendered  inaccessible  to  DNA  methyltransferases  by 
CTCF binding (Figure 2b). CTCF-binding sites were also 
identified in other transition areas between escape and 
inactivated genes, suggesting that CTCF may play a role 
in  the  insulation  of  escape  domains  [43].  However,  a 
subsequent study showed that insertion of CTCF-binding 
sites  from  the  HS4  insulator  site  (from  the  chicken 
b-globin  gene  cluster)  at  each  end  of  a  short  reporter 
gene was not sufficient to protect it from silencing when 
inserted within an inactivated gene on the Xi in mouse 
cells [44]. A more recent study reported that a bacterial 
artificial  chromosome  clone  containing  Kdm5c  and  its 
flanking regions retains its properties of escape even when 
inserted at other sites that are normally inactivated on the 
Xi in mouse cells [45]. CTCF-binding sites may turn out 
not  to  be  sufficient  for  insulation,  and  other  elements 
within or around escape genes may be important.
In particular, the structure of chromatin may have an 
important role in insulation by looping specific regions 
out of the condensed Xi (Figure 2a) [46]. Our recent X-
chromatin profiles show a discontinuous distribution of 
the repressive chromatin mark H3K27me3 along the Xi, 
consistent with the presence of insulator elements and/or 
specific  attachment  sites  for  looped  chromatin  [13]. 
However, in human × mouse hybrid cell lines, where the 
human  X  can  be  distinguished  from  the  rodent  back-
ground,  repressive  chromatin  marks  were  found  to  be 
progres  sively  diminished  in  the  intergenic  region 
between  the  inactivated  RBM10  (RNA-binding  motif 
protein 10) and the escape gene UBA1/UBE1 (ubiquitin-
like modifier activating enzyme). Specifically, H3K9me3 
and another histone modification associated with gene 
silencing, H4K20me3, were enriched in the last RBM10 
exon  but  were  already  depleted  approximately  2  kb 
upstream of UBA1/UBE1 [41].
Escape from X inactivation can vary between different 
tissues and/or individuals and the escape status can also 
be developmentally regulated. In humans, about 10% of 
X-linked  genes  show  variation  in  escape  in  different 
tissues  and/or  individuals  [12,47].  Some  escape  genes 
may  have  a  different  chromatin  structure  throughout 
development,  as  suggested  by  the  lack  of  promoter-
restricted H3K4me2 in undifferentiated ES cells before X 
inactivation  [48].  Other  escape  genes  may  be  initially 
silenced, and only reactivate in some tissues or with aging 
[33].  Individual  cells  may  also  vary:  in  an  analysis  of 
single-cell  allelic  expression  of  Kdm5c  in  mouse, 
significant  silencing  in  individual  embryonic  cells  was 
observed in contrast to consistent expression from both 
alleles  in  adult  cells  [49].  Differences  in  H3K27me3 
enrichment on some genes in a tissue and developmental-
stage-specific manner also suggest variability in escape 
[13]. For example, enrichment in H3K27me3 along Mid1 
(midline  1)  in  mouse  embryos  but  not  in  adult  liver 
suggests  removal  of  the  repressive  mark  in  a  tissue-
specific manner. It is possible that the recently identified 
histone demethylases KDM6A and KDM6B may facilitate 
the removal of H3K27me3 at escape genes [50-52].
Escape from early imprinted paternal X 
inactivation
Imprinted X inactivation silences the paternal X during 
the preimplantation stage (see Box 1). This imprinting is 
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random X inactivation [7]. It is not known whether im-
printed  X  inactivation  occurs  in  humans  and  the 
mechanisms for imprinted X inactivation in mice are still 
unclear. Are there genes that escape the initial imprinted 
X inactivation? Several recent studies have addressed this 
question  by  profiling  transcriptional  activity  from  the 
paternal X during early development. A specific set of 
genes apparently does escape imprinted X inactivation at 
the  two-cell  stage  [53,54].  However,  another  subset  of 
genes shows a variable escape status during development 
and  in  a  lineage-specific  manner.  For  example,  Huwe1 
(HECT, UBA and WWE domain containing 1) shows no 
evidence of silencing during pre-implantation stages but 
is efficiently silenced after implantation, whereas Kdm5c 
is partially inactivated during the preimplantation stage 
but  escapes  fully  throughout  the  rest  of  development, 
and Atrx (alpha thalassemia/mental retardation syndrome 
X-linked)  is  expressed  from  both  alleles  in 
extraembryonic ectoderm but not in trophectoderm (the 
precursor  of  some  extraembryonic  tissues  in  the 
preimplantation embryo), or in later embryos [13,49,53].
Escape from male-specific meiotic sex-
chromosome inactivation
In  male  spermatogenesis,  yet  another  type  of  X-
chromosome silencing takes place - MSCI [55] (see Box 1). 
Unlike  X  inactivation  in  female  somatic  cells,  where 
extensive analyses have catalogued the proportion of genes 
that escape silencing, no such study has been done so far 
for  MSCI.  However,  the  permissive  mark  H3K4me3  is 
present in discrete regions of the X in mouse pachytene 
spermatocytes. Furthermore, immunofluorescence stain-
ing for RNA polymerase II in these cells revealed several 
regions  of  transcriptional  activity,  suggesting  areas  of 
escape from MSCI [42]. Another study revealed that up 
to  86%  of  the  72  known  X-encoded  miRNAs  escape 
MSCI at different times during spermatogenesis. Some of 
the miRNAs were upregulated during MSCI and either 
downregulated  or  maintained  in  the  context  of  post-
meiotic  sex  chromatin  [14].  Recent  evidence  suggests 
that  repression  of  the  X  chromosome  due  to  MSCI 
persists,  at  least  in  part,  into  the  mature  sperm  [56], 
which could be important for suppression of oogenesis-
specific genes and/or dosage compensation by potentially 
enabling transmission of a partially inactivated paternal 
X [57]. However, not all sex-linked genes remain inacti-
vated  following  MSCI  and  evidence  points  to  mainte-
nance  of  post-meiotic  X-chromosome  repression  being 
incomplete. In fact, about 18% of X-linked genes, especially 
multicopy genes, are expressed in postmeiotic cells [58].
X  inactivation  is  an  important  process  required  to 
balance  gene  dosage  in  males  and  females.  Equally 
important  are  those  genes  that  escape  X  inactivation. 
Why is there a far greater number of X-linked genes that 
escape X inactivation in humans than in mice? Not only 
does  the  number  of  escape  genes  differ  but  also  their 
location. Human escape genes exist in large domains of 
escape whereas mouse escape genes are scattered along 
the X chromosome. Their location in recent evolutionary 
strata  in  humans  suggests  a  major  role  of  sex 
chromosome evolution in the retention of escape genes. 
However,  their  retention  may  also  be  linked  to  their 
inherent ability to cause sex-specific differences in gene 
expression  levels.  We  propose  that  the  complexity  of 
dosage  compensation  in  mammals,  which  involves  X 
upregulation, X inactivation, and escape from X inactiva-
tion, may have specific advantages in providing oppor-
tunities to modulate gene expression between the sexes 
in specific tissues. This may be especially advantageous in 
reproductive organs. Whether sex differences do lead to 
physiological effects remains to be determined. Specific 
epigenetic  mechanisms  may  have  evolved  to  ensure 
maintenance of escape from X inactivation. These may 
include the accumulation of repeats and DNA motifs to 
recruit or repel the silencing complex, as well as specific 
boundary elements. Future studies are needed to further 
characterize the chromatin structure of escape domains 
and to understand their role in evolution.
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